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Petros Nihoyannopoulos, MDI maging of the right ventricle (RV) has gainedpopularity. Terms such as “the forgottenventricle” or “difﬁculties in assessing RV func-
tion attributed to its shape” are frequently used as
opening statements in new research. Two things
make the RV challenging to assess by any imaging
modality: the thin wall and the overall asymmetric
shape in the form of a crescent shell covering part
of the left ventricle. The RV has also an anatomically
distinct inﬂow and outﬂow that are placed in
different planes.
What is important in diagnostic imaging is the
ability to link patterns or numbers to clinical out-
comes. While “a pretty picture is worth a thousand
words” holds true, the 5 general rules for a diag-
nostic test to be clinically useful are: to be feasible
for most patients, to be noninvasive (including
absence of ionizing radiation), to be consistent
between and within observers, to be cost-effective,
and to be linked to clinical outcomes. Cardiac mag-
netic resonance (CMR) generally fulﬁlls most of those
criteria and is probably cost-effective in the assess-
ment of RV function, for this it is widely perceived as
the reference method.
RV ejection fraction provides substantial func-
tional and prognostic information (1,2). This, until
recently, could only be determined by CMR or radio-
nuclide angiography with some accuracy. Two-
dimensional echocardiography cannot assess RV
ejection fraction and instead, several other surrogate
parameters have been advocated (3). Recently, a joint
effort between the American Society of Echocardiog-
raphy (ASE) and the European Association of Echo-
cardiography (EAE) published guidelines for the
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this paper to disclose.adults (4). These do not include ejection fraction but
rather a number of linear parameters, the most pop-
ular being the longitudinal motion by M-mode of the
tricuspid annular excursion (TAPSE). TAPSE is easily
obtainable and is a measure of RV longitudinal func-
tion. Although it only measures tricuspid annular
excursion and therefore the RV inﬂow track alone,
it has shown good correlation with radionuclide-
derived RV ejection fraction (5) and is recommended
by the joint ASE/EAE guidelines for routine use (4).
The main disadvantage, however, is that TAPSE as-
sumes that the displacement of a single segment
(tricuspid annulus) represents the overall function of
a complex structure, and there are no large-scale
validation studies for this.
It is only with the recent development of
3-dimensional (3D) echocardiography that attempts
to estimate RV ejection fraction by echocardiography
have re-emerged. As expected, all comparisons have
been made against CMR (6–9), and normal reference
values have been published (10). The use of 3D
echocardiography for valve disease and also for the
assessment of left and right ventricular function is
rapidly gaining acceptance, and guidelines have
been reported (11). In expert hands, 3D has become a
credible alternative to CMR for assessing RV volumes
albeit with some negative bias as indeed for the left
ventricular volumes calculations.
But is assessing RV volumes what we should be
doing in functional RV assessment? Until now we had
nothing else. There is no doubt that ejection fraction
is the best we can do today, and it is linked to out-
comes. Ventricular volume calculations are notori-
ously bad and are load dependent. Reproducibility
varies among imaging techniques from 10% to 20%
(and possibly more). Volume calculations have been
used because they are easily derived and there has
been little or no alternative. But there is more to
phenotyping heart disease, as CMR has shown, that
may be prognostically but also therapeutically more
exciting, namely, the detection and quantiﬁcation of
myocardial ﬁbrosis (12).
Myocardial ﬁbrosis leads to impaired cardiac dia-
stolic and systolic function and is related to adverse
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524cardiovascular events (13,14). Most of the studies,
however, are single-center and suffer from referral
bias. In the recent European Guidelines for Patients
With Hypertrophic Cardiomyopathy, CMR with late
gadolinium enhancement is a class IIa level B cate-
gory for the assessment of cardiac anatomy and
ventricular function and for the detection of
myocardial ﬁbrosis (15).
Myocardial strain calculation is a relatively novel
way to assess ventricular function. It provides angle-
independent assessment of regional myocardial
deformation and does not rely on geometric as-
sumptions (16). Longitudinal strain can quantify
systolic function, allows for the evaluation of regional
and global deformation properties of the myocar-
dium, and may be a more sensitive method to identify
subclinical left ventricular dysfunction (17). An
important study by Urbano-Moral et al. (18) showed
an association between myocardial ﬁbrosis detected
by CMR and regional effect on myocardial function.
Myocardial segments with hypertrophy and ﬁbrosis
had the most impaired regional function by all
deformation parameters.
More recently, studies using myocardial strain of
the RV have shown that RV systolic strain is a
powerful predictor of clinical outcome of patients
with known or suspected pulmonary hypertension
(19,20). This is potentially a breakthrough method
considering the thin-walled RV, which could be
challenging to assess with any imaging modality.
More recently, we used 3D strain in patients with
pulmonary arterial hypertension and found that
reduced area strain (AS), longitudinal strain, and
circumferential strain were all associated with
increased mortality risk (21). The new measurement
of AS had strong associations with RV ejection frac-
tion, whereas only AS was an independent predictor
of death on multivariable analysis, suggesting the
superiority of 3D–derived AS over other variables.
Normal values for RV strain have also been published
(22), thus moving a step closer to establishing strain
as a valuable alternative to RV assessment.SEE PAGE 514In this issue of iJACC, Lisi et al. (23) provide
new information regarding the correlation between
myocardial strain as assessed by echocardiography
and myocardial ﬁbrosis quantiﬁed histologically.
This is a signiﬁcant study because until now
most correlations were made against surrogate
techniques for myocardial ﬁbrosis, such as late
gadolinium enhancement using CMR. The authors
examined 27 patients with end-stage heart failure
undergoing cardiac transplantation and looked athistology for RV free wall ﬁbrosis, comparing
the ﬁndings with 2-dimensional strain by speckle
tracking echocardiography. The unique advantage
of this study is that the authors could look at tissue
samples of the RV free wall obtained from explan-
ted hearts. Histology was performed from 3 full-
thickness slices of the RV at basal, mid-, and api-
cal levels. Fibrosis was calculated as an average of
the 3 slices.
All patients were studied as part of their trans-
plantation work-up including electrocardiography,
cardiopulmonary exercise testing, and NT-pro-BNP
assays. A comprehensive echocardiographic assess-
ment included a number of standard parameters as
recommended by the ASE/EAE guidelines, including
TAPSE, RV sphericity, right atrial (RA) function, as
well as RA longitudinal stain. Seventeen (63%) pa-
tients had severe RV myocardial ﬁbrosis deﬁned as
>50% of myocardium. Not surprisingly, all echocar-
diographic parameters were also reduced. The major
ﬁnding of this study, however, was that RV ﬁbrosis
clearly correlated with free wall longitudinal strain
and oxygen consumption (VO2) max, but poorly
correlated with TAPSE and RA longitudinal strain. RV
free wall longitudinal strain was the main determi-
nant of myocardial ﬁbrosis and predicted the limited
exercise tolerance. Because of the nature of the study,
they were unable to ascertain the relationship be-
tween alterations of RV free wall longitudinal strain
and disease progression from subclinical disease to
severe RV dysfunction.
The study has also a number of limitations. The
etiology of RV dysfunction and ﬁbrosis was sec-
ondary to left heart disease of variable etiologies
(mostly ischemic [59%]), idiopathic cardiomyopathy
(37%), and 1 hypertrophic cardiomyopathy so that
most if not all would have had secondary (post-
capillary) pulmonary hypertension. These left heart
conditions are also responsible for myocardial
ﬁbrosis of the left ventricle and therefore relating
with other patients’ clinical data may not be valid.
The echo analysis was performed by excluding the
ventricular septum, which is a good thing as its in-
clusion would have diluted their data because it
would contain left heart abnormalities. The authors
studied patients with end-stage heart failure with
marked RV enlargement. In other words, they
studied the worst of the worst scenarios, and it is
not possible to extrapolate to patients with less se-
vere heart failure or patients with precapillary pul-
monary hypertension. Finally, they do not provide
any information about cardiac arrhythmias. Studies,
particularly in cardiomyopathy patients, have shown
an association between ﬁbrosis (assessed by CMR)
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525and arrhythmia. It would have been of interest for
the authors to show us the extent of ﬁbrosis by
disease, but the number of patients would have
been limited.
So, is assessing RV ﬁbrosis the holy grail of RV
imaging? These data do not provide sufﬁcient sup-
port, but it is clearly a step forward to encourage
further prospective studies looking at the predictivevalue of advancing ﬁbrosis on RV strain in patients
with pulmonary hypertension.
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